Source: BioPortfolio

Tetragenetics: TetraGenetics and ImmunoPrecise Extend Collaboration With MultiTarget Service Agreement

ImmunoPrecise Antibodies TSXVIPA OTC PinkIPATF has announced it has extended its collaboration with TetraGenetics. As quoted in the press release The alliance is focused on the discovery of novel human monoclonal antibodies against three undisclosed therap...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Douglas R. Kahn's photo - Chairman & CEO of Tetragenetics

Chairman & CEO

Douglas R. Kahn

CEO Approval Rating

87/100

Read more